Hemas Holdings Plc (HHL.N0000) Stock Analysis | Price, Returns, Financials & Key Metrics

Price Point

High/Low

1Day

52 Week

Valuation

Technical

Day's Volume

CASH

N/A

Shareholding

FII

N/A

DII

N/A

Promoter

N/A

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.Unlock 29 Markets

Dashboard

Company's ability to service its debt is strong with a healthy EBIT to Interest (avg) ratio of 6.95

Low Debt Company with Strong Long Term Fundamental Strength

Positive results in Jun 25

With ROE of 17.59%, it has a attractive valuation with a 2.18 Price to Book Value

Market Beating Performance

Mojo Parameters

Stock DNA

Industry

Pharmaceuticals & Biotechnology

Market cap

LKR 104,827 Million (Large Cap)

P/E

12.00

Industry P/E

Dividend Yield

0.00%

Debt Equity

-0.01

Return on Equity

17.98%

Price to Book

2.06

Revenue and Profits:

Net Sales:

28,526 Million

(Quarterly Results - Jun 2025)

Net Profit:

1,255 Million

Total Returns

Total Returns (Price + Dividend)

TimePeriod

Price Return

Dividend Return

Total Return

3 Months

21.67%

6 Months

26.3%

1 Year

100.11%

2 Years

153.47%

3 Years

-36.3%

4 Years

160.71%

5 Years

-61.7%

Hemas Holdings Plc for the last several years.

Risk Adjusted Returns v/s

News & Corporate Actions

News

No Recent News for the Company

Announcements

No announcement available

Corporate Actions

No corporate action available

Key Factors

Quality key factors

Factor

Value

Sales Growth (5y)

14.75%

EBIT Growth (5y)

23.86%

EBIT to Interest (avg)

6.95

Debt to EBITDA (avg)

Net Debt is too low

Net Debt to Equity (avg)

-0.13

Sales to Capital Employed (avg)

2.05

Tax Ratio

35.76%

Dividend Payout Ratio

33.36%

Pledged Shares

Institutional Holding

ROCE (avg)

24.07%

ROE (avg)

14.05%

Valuation key factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

2.18

EV to EBIT

8.23

EV to EBITDA

7.03

EV to Capital Employed

2.31

EV to Sales

0.84

PEG Ratio

Dividend Yield

0.06%

ROCE (Latest)

28.02%

ROE (Latest)

17.59%

Technicals key factors

Indicator

Weekly

Monthly

MACD

Mildly Bearish

Bullish

RSI

No Signal

Bearish

Bollinger Bands

Bullish

Moving Averages

Bullish (Daily)

KST

Bullish

Dow Theory

Mildly Bullish

OBV

No Trend

Bullish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Shareholding

Shareholding Snapshot

No data for shareholding present.

Shareholding Compare (%holding)

No data for shareholding present.

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Jun 2025 is -6.00% vs -8.69% in Mar 2025",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Jun 2025 is -52.50% vs -14.88% in Mar 2025",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Jun'25",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "28,525.80",
          "val2": "30,347.20",
          "chgp": "-6.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "2,453.40",
          "val2": "3,643.40",
          "chgp": "-32.66%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "251.10",
          "val2": "354.90",
          "chgp": "-29.25%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "1,255.30",
          "val2": "2,642.60",
          "chgp": "-52.50%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "66.30%",
          "val2": "101.00%",
          "chgp": "-3.47%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Mar'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2025 is -3.00% vs 6.74% in Mar 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2025 is 31.22% vs 25.37% in Mar 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Mar'25",
        "Mar'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "117,970.20",
          "val2": "121,613.80",
          "chgp": "-3.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "14,160.30",
          "val2": "12,756.40",
          "chgp": "11.01%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "1,500.40",
          "val2": "3,254.60",
          "chgp": "-53.90%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "336.20",
          "val2": "265.00",
          "chgp": "26.87%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "8,338.70",
          "val2": "6,354.70",
          "chgp": "31.22%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "103.10%",
          "val2": "91.10%",
          "chgp": "1.20%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQ

Jun'25

Mar'25

Change(%)

Net Sales

28,525.80

30,347.20

-6.00%

Operating Profit (PBDIT) excl Other Income

2,453.40

3,643.40

-32.66%

Interest

251.10

354.90

-29.25%

Exceptional Items

0.00

Consolidate Net Profit

1,255.30

2,642.60

-52.50%

Operating Profit Margin (Excl OI)

66.30%

101.00%

-3.47%

USD in Million.

Compare with Peers

Net Sales

QoQ Growth in quarter ended Jun 2025 is -6.00% vs -8.69% in Mar 2025

Consolidated Net Profit

QoQ Growth in quarter ended Jun 2025 is -52.50% vs -14.88% in Mar 2025

All Quarterly Results

Annual Results Snapshot (Consolidated) - Mar'25

Mar'25

Mar'24

Change(%)

Net Sales

117,970.20

121,613.80

-3.00%

Operating Profit (PBDIT) excl Other Income

14,160.30

12,756.40

11.01%

Interest

1,500.40

3,254.60

-53.90%

Exceptional Items

336.20

265.00

26.87%

Consolidate Net Profit

8,338.70

6,354.70

31.22%

Operating Profit Margin (Excl OI)

103.10%

91.10%

1.20%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Mar 2025 is -3.00% vs 6.74% in Mar 2024

Consolidated Net Profit

YoY Growth in year ended Mar 2025 is 31.22% vs 25.37% in Mar 2024

All Annual Results

Company CV

About Hemas Holdings Plc

Hemas Holdings Plc

Pharmaceuticals & Biotechnology

Hemas Holdings PLC (Hemas) is a Sri Lanka-based pharmaceuticals company engaged in healthcare, leisure and transportation services. The Company operates in various segments, such as FMCG, Healthcare, Leisure, Transportation, Power and others. The FMCG business sector manufactures and markets personal care and home care branded products. Its Healthcare sector is a distributor of pharmaceuticals, surgical and diagnostic products in Sri Lanka. Its Leisure sector consists of the Serendib Leisure Group of Hotels. The Transportation sector consists of the aviation business both in the passenger and cargo segments, its maritime business providing feeder operations and agency services for international shipping partners, its outbound travel agency services via Hemas Travels and its logistics business unit consists of integrated logistic services.

Company Coordinates

Company Details

No 75, Braybrooke Place, Colombo 02 , COLOMBO None : 01

Tel: 94 11 4731713

http://www.hemas.com

Registrar Details